190 related articles for article (PubMed ID: 31182531)
1. Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus.
Lindman M; Dick T
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182531
[TBL] [Abstract][Full Text] [Related]
2. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
[TBL] [Abstract][Full Text] [Related]
3. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
Raynaud C; Daher W; Roquet-Banères F; Johansen MD; Stec J; Onajole OK; Ordway D; Kozikowski AP; Kremer L
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32041716
[TBL] [Abstract][Full Text] [Related]
5.
Martins O; Lee J; Kaushik A; Ammerman NC; Dooley KE; Nuermberger EL
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0154521. PubMed ID: 34516254
[TBL] [Abstract][Full Text] [Related]
6.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
7. New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the
Kaushik A; Ammerman NC; Parrish NM; Nuermberger EL
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209013
[TBL] [Abstract][Full Text] [Related]
8. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
[TBL] [Abstract][Full Text] [Related]
9. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
[TBL] [Abstract][Full Text] [Related]
10. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
[TBL] [Abstract][Full Text] [Related]
11.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
12. TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
Sarathy JP; Ganapathy US; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964791
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice.
Le Moigne V; Raynaud C; Moreau F; Dupont C; Nigou J; Neyrolles O; Kremer L; Herrmann JL
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253217
[No Abstract] [Full Text] [Related]
14.
Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
[TBL] [Abstract][Full Text] [Related]
15. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in
Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H
Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492
[TBL] [Abstract][Full Text] [Related]
16. Select β-Lactam Combinations Exhibit Synergy against
Story-Roller E; Maggioncalda EC; Lamichhane G
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
[No Abstract] [Full Text] [Related]
17. Differential
Lee J; Ammerman N; Agarwal A; Naji M; Li SY; Nuermberger E
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168614
[TBL] [Abstract][Full Text] [Related]
18. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
[TBL] [Abstract][Full Text] [Related]
19.
Schulthess B; Akdoğan Kittana FN; Hömke R; Sander P
Antimicrob Agents Chemother; 2022 May; 66(5):e0234621. PubMed ID: 35420492
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Efficacy of β-Lactam Combinations against
Story-Roller E; Maggioncalda EC; Lamichhane G
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
